Caricamento...
小分子抗血管生成药物在非小细胞肺癌中的研究进展
Lung cancer is one of the cancers with the highest incidence in the world, and there is no standard treatment plan after second-line progression. Tumor angiogenesis has now been identified as an important therapeutic target for malignant tumors. Small molecule multi-target vascular kinase inhibitors...
Salvato in:
| Pubblicato in: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
中国肺癌杂志编辑部
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7849040/ https://ncbi.nlm.nih.gov/pubmed/33478192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.02 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|